https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 The origin of circulating CD36 in type 2 diabetes https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20054 c. By contrast, the main source of CD36+MPs in non-T2DM individuals was endothelial cells (CD105+=40.9±8.3% and 33.9±8.3% for lean and obese controls, respectively). Across the entire cohort, plasma CD36 protein concentration varied from undetectable to 22.9 μg ml⁻¹ and was positively correlated with CD36+MPs measured by flow cytometry (P=0.0006) but only weakly associated with the distribution of controls and T2DM (P=0.021). Multivariate analysis confirmed that plasma CD36+MP levels were a much better biomarker for diabetes than CD36 protein concentration (P=0.009 vs P=0.398, respectively). Conclusions: Both the levels and cellular profile of CD36+MPs differ in T2DM compared with controls, suggesting that these specific vesicles could represent distinct biological vectors contributing to the pathology of the disease.]]> Wed 11 Apr 2018 16:13:53 AEST ]]> The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:9178 Wed 11 Apr 2018 15:35:19 AEST ]]> Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25886 Sat 24 Mar 2018 07:25:52 AEDT ]]>